How to Halve Your Risk of Heart Disease

  • 14 Sep 2010
  • Reading time 14 mins
Login to add to reading list

More people die prematurely from diseases of the heart and arteries than anything else – 150,000 a year in England alone, roughly half from heart attacks and a quarter from strokes, according to current statistics from the British Heart Foundation.

Niacin vs statins for lowering cholesterol For decades now we’ve been told to take cholesterol-lowering statin drugs despite the fact that they are remarkably ineffective unless you are a man and have already had a heart attack. Just how poor the evidence is and how little effort has been made to discover the number of people troubled by side-effects was highlighted in a review of statins by the respected Cochrane Collaboration at the beginning of 2010. It analysed trials involving 34,272 people who hadn't had a heart attack and found little evidence that taking a statin would protect people from having a first heart attack unless their risk was classified as high. These are drugs given to about four and a half million healthy people in the UK.

A study in the Lancet five years ago found that even though the drugs prevented a few heart attacks, none of the patients lived any longer as a result. That’s bad enough – if you are told this pill will cut your risk of a heart attack, you assume that it will also make you live longer. But it gets worse. Men over 69 didn’t benefit from taking statins at all. They didn’t live longer and didn’t have fewer heart attacks, and women of any age didn’t benefit either. That’s right, not at all. Niacin (vitamin B3) is available on prescription in high doses of 500mg. It is by far the most effective cholesterol-lowering substance because it not only lowers the ‘bad’ LDL, it also lowers triglycerides and lipoprotein(a) – all by about a quarter, and it raises the good HDL. No drug does all this. It also reverses atherosclerosis (arterial thickening) and risk of cardiovascular events. Quite a few studies have proven its benefit when given with statins, versus statins alone, although one recent trial failed to show a clinical benefit.

The best review on niacin, published in Pharmacology and Therapeutics last year, is by Dr John Chapman and colleagues who concludes “available clinical evidence demonstrates that niacin-based therapies ......

The full content of this report is only viewable by 100% Health Club members.

MEMBERS have free access to 100's of Reports, a monthly 100% Health Newsletter, free use of the 100% Health programme with unlimited reassessments and big discounts, up to 30% off books, supplements and             foods at


Find out more